|
1
|
Yabe M, Miranda RN and Medeiros LJ:
Hepatosplenic T-cell lymphoma: A review of clinicopathologic
features, pathogenesis and prognostic factors. Hum Pathol. 74:5–16.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
A clinical evaluation of the International
Lymphoma Study Group classification of non-Hodgkin's lymphoma. The
Non-Hodgkin's Lymphoma Classification Project. Blood. 89:3909–3918.
1997.PubMed/NCBI
|
|
3
|
Sun J, Yang Q, Lu Z, He M, Gao L, Zhu M,
Sun L, Wei L, Li M, Liu C, et al: Distribution of lymphoid
neoplasms in China: Analysis of 4,638 cases according to the World
Health Organization classification. Am J Clin Pathol. 138:429–434.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Han Z, Niu T, Chang J, Lei X, Zhao M, Wang
Q, Cheng W, Wang J, Feng Y and Chai J: Crystal structure of the FTO
protein reveals basis for its substrate specificity. Nature.
464:1205–1209. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sabattini E, Bacci F, Sagramoso C and
Pileri SA: WHO classification of tumours of haematopoietic and
lymphoid tissues in 2008: An overview. Pathologica. 102:83–87.
2010.PubMed/NCBI
|
|
6
|
Tohda S: Overview of lymphoid neoplasms in
the fourth edition of the WHO classification. Rinsho Byori.
60:560–564. 2012.(In Japanese). PubMed/NCBI
|
|
7
|
Lee Y, Uhm JE, Lee HY, Park MJ, Kim H, Oh
SJ, Jang JH, Kim K, Jung CW, Ahn YC, et al: Clinical features and
prognostic factors of patients with ‘peripheral T cell lymphoma,
unspecified’. Ann Hematol. 88:111–119. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Petrich AM and Rosen ST: Peripheral T-cell
lymphoma: New therapeutic strategies. Oncology (Williston Park,
NY). 27:878–884. 2013.
|
|
9
|
Bridgewater J, Galle PR, Khan SA, Llovet
JM, Park JW, Patel T, Pawlik TM and Gores GJ: Guidelines for the
diagnosis and management of intrahepatic cholangiocarcinoma. J
Hepatol. 60:1268–1289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cao X, Fang L, Gibbs S, Huang Y, Dai Z,
Wen P, Zheng X, Sadee W and Sun D: Glucose uptake inhibitor
sensitizes cancer cells to daunorubicin and overcomes drug
resistance in hypoxia. Cancer Chemother Pharmacol. 59:495–505.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu X, Pertovaara H, Korkola P, Vornanen M,
Eskola H and Kellokumpu-Lehtinen PL: Glucose metabolism correlated
with cellular proliferation in diffuse large B-cell lymphoma. Leuk
Lymphoma. 53:400–405. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu T, Kishton RJ, Macintyre AN, Gerriets
VA, Xiang H, Liu X, Abel ED, Rizzieri D, Locasale JW and Rathmell
JC: Glucose transporter 1-mediated glucose uptake is limiting for
B-cell acute lymphoblastic leukemia anabolic metabolism and
resistance to apoptosis. Cell Death Dis. 5:e14702014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zois CE and Harris AL: Glycogen metabolism
has a key role in the cancer microenvironment and provides new
targets for cancer therapy. J Mol Med (Berl). 94:137–154. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vose JM: Update on T-cell lymphoma. Ann
Oncol. 19 Suppl 4:iv74–iv76. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang R, Dong K, Lin F, Wang X, Gao P, Wei
SH, Cheng SY and Zhang HZ: Inhibiting proliferation and enhancing
chemosensitivity to taxanes in osteosarcoma cells by RNA
interference-mediated downregulation of stathmin expression. Mol
Med. 13:567–575. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shao Y, Ling CC and Liu XQ: High
concentrations of glucose suppress etoposide-induced cell death of
B-cell lymphoma through BCL-6. Biochem Biophys Res Commun.
450:227–233. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ouchi N, Parker JL, Lugus JJ and Walsh K:
Adipokines in inflammation and metabolic disease. Nat Rev Immunol.
11:85–97. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y, Proenca R, Maffei M, Barone M,
Leopold L and Friedman JM: Positional cloning of the mouse obese
gene and its human homologue. Nature. 372:425–432. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cioffi JA, Shafer AW, Zupancic TJ,
Smith-Gbur J, Mikhail A, Platika D and Snodgrass HR: Novel B219/OB
receptor isoforms: Possible role of leptin in hematopoiesis and
reproduction. Nat Med. 2:585–589. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bennett BD, Solar GP, Yuan JQ, Mathias J,
Thomas GR and Matthews W: A role for leptin and its cognate
receptor in hematopoiesis. Curr Biol. 6:1170–1180. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feller AC: Phenotypic analysis of human
T-cell lymphoma with reference to cell differentiation and
morphological classification. Veroff Pathol. 131:1–175. 1989.(In
German). PubMed/NCBI
|
|
23
|
Smith JL, Hodges E, Howell WM and Jones
DB: Genotypic heterogeneity of node based peripheral T-cell
lymphoma. Leuk Lymphoma. 10:273–279. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shao W, Growney JD, Feng Y, O'Connor G, Pu
M, Zhu W, Yao YM, Kwon P, Fawell S and Atadja P: Activity of
deacetylase inhibitor panobinostat (LBH589) in cutaneous T-cell
lymphoma models: Defining molecular mechanisms of resistance. Int J
Cancer. 127:2199–2208. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vaisse C, Halaas JL, Horvath CM, Darnell
JE Jr, Stoffel M and Friedman JM: Leptin activation of Stat3 in the
hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat
Genet. 14:95–97. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fernández-Formoso G, Pérez-Sieira S,
González-Touceda D, Dieguez C and Tovar S: Leptin, 20 years of
searching for glucose homeostasis. Life Sci. 140:4–9. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pliszka M, Oleszczak B and Szablewski L:
Leptin at gender-specific concentrations does not affect glucose
transport, expression of glucose transporters and leptin receptors
in human lymphocytes. Endocrine. 49:97–105. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Saucillo DC, Gerriets VA, Sheng J,
Rathmell JC and Maciver NJ: Leptin metabolically licenses T cells
for activation to link nutrition and immunity. J Immuno.
192:136–144. 2014. View Article : Google Scholar
|
|
29
|
Jacobs SR, Herman CE, Maciver NJ, Wofford
JA, Wieman HL, Hammen JJ and Rathmell JC: Glucose uptake is
limiting in T cell activation and requires CD28-mediated
Akt-dependent and independent pathways. J Immunol. 180:4476–4486.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Loffreda S, Yang SQ, Lin HZ, Karp CL,
Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, et al:
Leptin regulates proinflammatory immune responses. FASEB J.
12:57–65. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
de Git KC and Adan RA: Leptin resistance
in diet-induced obesity: The role of hypothalamic inflammation.
Obesity Rev. 16:207–224. 2015. View Article : Google Scholar
|
|
32
|
van Dielen FM, van't Veer C, Schols AM,
Soeters PB, Buurman WA and Greve JW: Increased leptin
concentrations correlate with increased concentrations of
inflammatory markers in morbidly obese individuals. Int J Obes
Relat Metab Disord. 25:1759–1766. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Park HY, Kwon HM, Lim HJ, Hong BK, Lee JY,
Park BE, Jang Y, Cho SY and Kim HS: Potential role of leptin in
angiogenesis: Leptin induces endothelial cell proliferation and
expression of matrix metalloproteinases in vivo and in vitro. Exp
Mol Med. 33:95–102. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Uddin S, Bu R, Ahmed M, Hussain AR, Ajarim
D, Al-Dayel F, Bavi P and Al-kuraya KS: Leptin receptor expression
and its association with PI3K/AKT signaling pathway in diffuse
large B-cell lymphoma. Leuk Lymphoma. 51:1305–1314. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim JY, Park HK, Yoon JS, Kim SJ, Kim ES,
Song SH, Choi JH, Kim BK, Park BB and Lee YY: Molecular mechanisms
of cellular proliferation in acute myelogenous leukemia by leptin.
Oncol Rep. 23:1369–1374. 2010.PubMed/NCBI
|
|
36
|
Procaccini C, De Rosa V, Galgani M,
Carbone F, Cassano S, Greco D, Qian K, Auvinen P, Calì G, Stallone
G, et al: Leptin-induced mTOR activation defines a specific
molecular and transcriptional signature controlling CD4+
effector T cell responses. J Immunol. 189:2941–2953. 2012.
View Article : Google Scholar : PubMed/NCBI
|
